Breakthrough Properties Acquires Life Science Asset for $159 Million 

Breakthrough Properties Acquires Life Science Asset for $159 Million 

On February 3, Breakthrough Properties announced that it acquired a three-building life science portfolio in Torrey Pines, California from Diversified Healthcare Trust (DHC).  The 186,000-square-foot portfolio is called MUSE and is 49% leased, with a weighted average lease term of more than eight years. The price is roughly $855 per square foot.  Breakthrough Properties, a joint venture of global developer Tishman Speyer and biotechnology investment firm Bellco Capital, is a life science real estate development company that leverages cross-sector collaboration to deliver environments that foster innovation and scientific breakthroughs.  DHC is a real estate investment trust... Read More »
Exploring the MedSpa M&A Market: Trends, Drivers and 2025 Outlook

Exploring the MedSpa M&A Market: Trends, Drivers and 2025 Outlook

Medical spas, or MedSpas, are hybrid establishments combining the luxury of a traditional spa with medical-grade aesthetic procedures. As an intersection of health, beauty and medicine, MedSpas have seen a surge in popularity in recent years. As wellness and aesthetic care continue to gain prominence in the daily lives of millions, the medical spa sector has become a focal point for M&A, reflecting a robust market landscape poised for further growth. The MedSpa sector’s prominence was evident at various healthcare conferences attended by the LevinPro HC team in 2024. During McGuireWoods’ 17th Annual Healthcare Finance and Growth Conference in September 2024, Eugene Goldenberg of... Read More »
Vitalis Announces First Acquisition of 2025 

Vitalis Announces First Acquisition of 2025 

Vitalis announced that it acquired a 33,000-square-foot ambulatory surgery center (ASC) in Lakeside, Arizona for $8.25 million. The transaction closed on January 31st, 2025.  The ASC, Aspen Ridge Surgical and Medical Complex, also operates a medical outpatient building (MOB). The ASC is 100% leased to five tenants with approximately 6.5 years of weighted average lease term. The facility is anchored by Amsurg, Copa Health and Premier Mountain Imaging.   The ASC is a joint venture between Amsurg and seven surgeons specializing in joint replacement, orthopedic, spine, podiatry and ear, nose and throat procedures. Copa Health is a regional health system with 500 employees and... Read More »
ESJ Capital Partners Acquires Medical Outpatient Building Portfolio for $16 Million 

ESJ Capital Partners Acquires Medical Outpatient Building Portfolio for $16 Million 

On January 31, ESJ Capital Partners announced that it was acquiring a Pennsylvania-based medical outpatient building (MOB) portfolio for $16 million.   The 152,310-square-foot, nine-building MOB portfolio is located in Langhorne, Pennsylvania. The portfolio is currently more than 70% leased to established medical tenants, among them Quest Diagnostics, DaVita, LabCorp and the American Red Cross. The purchase price for the MOB portfolio is approximately $105 per square foot.  ESJ Capital Partners, founded in 2008, is a real estate investment firm with offices in Miami, Florida and Luxembourg, specializing in value-add opportunities across the United States. Offering a... Read More »
Lantheus to Acquire Evergreen Theragnostics for Upfront Payment of $250 Million

Lantheus to Acquire Evergreen Theragnostics for Upfront Payment of $250 Million

Lantheus Holdings, Inc. announced on January 8 a definitive agreement to acquire Evergreen Theragnostics, Inc. in an all-cash transaction of an upfront payment of $250 million and up to an additional $752.5 million in potential milestone payments. The transaction is expected to solidify Lantheus’ capabilities as a fully integrated radiopharmaceutical company and is expected to close in the second half of 2025. Founded in 2019, Evergreen Theragnostics is focused on improving the available options for cancer patients using radiopharmaceuticals. The company is engaged in contract development and manufacturing (CDMO) services, as well as drug discovery and commercialization of... Read More »
Lantheus to Acquire Evergreen Theragnostics for Upfront Payment of $250 Million

Cormica Expands In The U.S. With Focus Laboratories Acquisition 

U.K.-based Cormica, backed by mid-market private equity Limerston Capital, announced on January 28 that it is furthering its expansion strategy with the acquisition of U.S.-based Focus Laboratories. This marks Cormica’s second acquisition in the United States. Focus Laboratories specializes in microbiological testing, including rapid microbiology and consulting for the pharmaceutical, biotech and medical device sectors. Focus Laboratories, originally founded in 1996, was acquired in 2016 by Tony Grilli. Cormica (formerly known as WMP Group) is a global contract research organization, providing comprehensive testing services for medical device, combination device and pharmaceutical... Read More »